Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Sarasota FL, Durham NC, San Antonio TX, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase1, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Sarasota FL, Miami FL, Atlanta GA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase1, Recruiting
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: Sarasota FL, New York NY, Denver CO
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT05463263
Phase1, Phase2, Recruiting
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
for
Cancer, Cancer, Lung
Location: Sarasota FL, Celebration FL, Nashville TN, Fairfax VA,
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05948865
Phase1, Recruiting
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
for
Advanced Solid Tumor, Metastatic Breast Cancer
Location: Sarasota FL, Lake Mary FL, Nashville TN, Houston TX
Sponsor: Edgewood Oncology Inc.
Sex: All
Age: 18+
Code: NCT04872166
Phase1, Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Sarasota FL, Nashville TN, Houston TX, Fairfax VA,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase1, Phase2, Recruiting
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Sarasota FL, Nashville TN, Richmond VA, Louisville KY,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06028074
Phase1, Phase2, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors